DEC 28, 2021 7:00 AM PST

Blood-Sucking Worms No Match Against Vaccine Pill

WRITTEN BY: Tara Fernandes

Ancylostoma caninum, a type of hookworm, attached to the intestinal mucosa. Image via Wikimedia Commons.

Hookworms are blood-sucking parasites that get their name from their characteristic hook-shaped heads. For a small worm (roughly the width of a fingernail), hookworms have a massive impact on global health. The parasite spreads through dirty water, infecting tens of millions of people every year.

In a recent scientific breakthrough, Australian researchers have brought forward a hookworm vaccine with tremendous promise. The vaccine was developed by a team led by Istvan Toth from the University of Queensland and can be administered in a tablet, liquid, or powder form. This flexibility is particularly beneficial for deploying the vaccine in under-resourced regions. The treatment has no special cold storage requirements and doesn't need to be given out by trained healthcare personnel.

Most of all, the vaccine is cost-effective, giving it the potential to boost economic growth in disease-endemic geographies without a hefty price tag.

The researchers performed a series of experiments in an animal model of hookworm infection to test the vaccine's efficacy. They pitted their vaccine against another leading experimental vaccine candidate to measure the relative reduction in worms after treatment. The control vaccine was shown to achieve a 30 to 50 percent dip in the number of worms isolated in vaccinated animals (compared to unvaccinated ones).

The team's vaccine performed significantly better. "The UQ-developed vaccine resulted in an impressive 94 percent worm reduction in mice," said Toth. This finding indicates that while being easy to deliver, the new vaccine also sets off a robust, protective immune response.

The vaccine works by igniting antibodies against a key enzyme produced by hookworms that they need to survive, called APR-1. When antibodies block APR-1, hookworms cannot digest their host's blood, ultimately dying from starvation. 

Next up, the team plans to perform a suite of follow-on studies to ensure the safety and efficacy of their vaccine candidate before proceeding to test it in a clinical trial setting.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
MAR 23, 2022
Immunology
Drug That Reverses Immune Aging Can Prevent COVID-19 Death
MAR 23, 2022
Drug That Reverses Immune Aging Can Prevent COVID-19 Death
As we age, parts of our bodies get old and worn out, including the immune system. That's one reason why COVID-19 has bee ...
APR 27, 2022
Clinical & Molecular DX
Asthma Risk Increased in Children Conceived with Infertility Treatment
APR 27, 2022
Asthma Risk Increased in Children Conceived with Infertility Treatment
Asthma is a disease characterized by difficulty breathing, and an asthma attack can bring on bouts of coughing and wheez ...
APR 28, 2022
Immunology
Lipid Supplement May Reduce Inflammation in MS
APR 28, 2022
Lipid Supplement May Reduce Inflammation in MS
Administration of an inflammation-mediating lipid has shown promise in reducing multiple sclerosis-related inflammation ...
JUN 01, 2022
Clinical & Molecular DX
Personalized Cancer Vaccine Showing Promise in Treating Melanoma and Ovarian Cancer
JUN 01, 2022
Personalized Cancer Vaccine Showing Promise in Treating Melanoma and Ovarian Cancer
Cancer vaccines have been around for decades, but a unique neoantigen vaccine called NeoVax is making researchers hopefu ...
MAY 25, 2022
Immunology
Dietary Cholesterol Exacerbates Flu Infection
MAY 25, 2022
Dietary Cholesterol Exacerbates Flu Infection
Diets that are high in fats and cholesterol have been associated with a variety of health problems, including an increas ...
JUN 07, 2022
Neuroscience
Dancing Improves Mental Health
JUN 07, 2022
Dancing Improves Mental Health
  A study published in Complementary Therapies in Clinical Practice found that dance has physical and mental health ...
Loading Comments...